China's medical products administrator approved North China Pharmaceutical's (SHA:600812) cobamide capsules, according to a Wednesday filing with the Shanghai bourse.
The capsules, which contain adenosylcobalamin, is primarily used for the prevention of wasting diseases, hyperthyroidism, megaloblastic anemia, and as supplements for pregnant and lactating mothers, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.